has been cited by the following article(s):
|
[1]
|
Repaglinide-Indinavir Pharmacokinetic and Pharmacodynamic Interaction: Non-Clinical Evaluation in Hepatic and Diabetic Impairment models
International Journal of Pharmaceutical Sciences and Developmental Research,
2026
DOI:10.17352/ijpsdr.000059
|
|
|
|
|
[2]
|
LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats
Analytical Methods,
2025
DOI:10.1039/D5AY01451D
|
|
|
|